The development of ATMPs requires a multidisciplinary approach, combining expertise in cell and gene therapy, manufacturing, and clinical application. This session focuses on the power of collaboration in advancing ATMP innovation. These therapies represent a new frontier in medicine, offering the potential to treat or even cure diseases previously considered untreatable. If you want to learn from industry leaders about the partnerships and frameworks accelerating progress in this dynamic field, this session is tailored for you!